1. P5650Cyclic guanosine monophosphate enhancing therapeutic strategy for heart failure with preserved ejection fraction (cGETS study): effects on cardiac dysfunction and remodeling. (28th August 2018) Authors: Dal Canto, E; Van Heerebeek, L; Franssen, C; Verheugt, F W A; Riezebos, R; Paulus, W J Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Systemic microvascular response to insulin is associated with risk of heart failure with preserved ejection fraction in women with type 2 diabetes. (3rd October 2022) Authors: Dal Canto, E; Van Deursen, L; Elders, P; Hoek, A; Den Ruijter, H M; Van Empel, V; Eringa, E C; Beulens, J W J Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Why are there ethnic differences in cardio-metabolic risk factors and cardiovascular diseases?. (December 2018) Authors: Dal Canto, E; Farukh, B; Faconti, L Journal: JRSM cardiovascular disease Issue: Volume 7(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗